Medicine and Dentistry
Chemotherapy
100%
In Vitro
100%
Hematologic Malignancy
100%
Arsenic Trioxide
100%
Patient
100%
Therapeutic Procedure
100%
Diseases
50%
Acute Promyelocytic Leukemia
50%
Combination Therapy
50%
Anthracycline
50%
Recurrence Risk
50%
Anticarcinogen
50%
Glutathione
50%
Chemotherapeutic Agent
50%
Reducing Agent
50%
Mechanism of Action
50%
Clinical Support
50%
INIS
patients
100%
in vitro
100%
malignancies
100%
arsenic
100%
data
50%
range
50%
therapy
50%
diseases
50%
investigations
50%
leukemia
50%
chemotherapy
50%
glutathione
50%
reducing agents
50%
Pharmacology, Toxicology and Pharmaceutical Science
Hematologic Malignancy
100%
Arsenite
100%
Diseases
50%
Anthracycline
50%
Combination Therapy
50%
Anticarcinogen
50%
Promyelocytic Leukemia
50%
Glutathione
50%
Reducing Agent
50%
Recurrence Risk
50%